empathy deficits occur before illness-onset in those at 'ultra-high risk' of psychosis (UHR) and those with a 'first-episode of psychosis' (FEP). Empathy defects are associated with neurological abnormalities, which have been studied separately in UHR, FEP and SCZ populations. This review aims to gain further insight into neurological changes associated with illness progression, by comparing brain changes associated with empathy across UHR, FEP and SCZ populations. Methods: Studies considering functional activity, connectivity and structural changes in UHR, FEP and SCZ populations were systematically reviewed. Data from 26 studies was used. Results: All three subgroups showed abnormal patterns of activation and connectivity across a range of regions, particularly in the frontal, limbic and temporal areas. Structural abnormalities appeared as widespread grey matter loss, largely in the temporal lobe, across all three participant groups. Notably, impaired empathic behavioural responses were found in FEP and SCZ subjects only, despite abnormal brain patterns in all three groups. Discussion: Our findings suggest that abnormal connectivity, structure and activation of the frontal, limbic and temporal areas contribute significantly to empathy deficits, and also worsen with illness progression. However, the multifaceted nature of empathy means that behavioural impairments likely result from a combination of disruptions of the frontal, limbic and temporal areas as well as many other neural networks involved in social information processing. Background: Motivation deficits predict decreased functioning in schizophrenia. Recent work suggests deficits reflect challenges in separate domains: intrinsic motivation (one's internal drive to engage in a behavior out of enjoyment or interest) and amotivation (one's broader decrease in motivated behavior linked to avolition and anhedonia). Internalized stigma is another determinant of functioning for people with schizophrenia that may impact motivation. However, little is known about these relationships, including which aspects of motivation it may impact nor when these links emerge. Identifying the link between these constructs may help to identify whether internalized stigma may be a novel treatment target to facilitate improvements in motivation. Methods: Forty adults with early phase schizophrenia and 66 adults with prolonged schizophrenia completed measures of internalized stigma, intrinsic motivation, and amotivation. Pearson's correlations were examined followed by Fischer's r-to-z transformations to compare differences in the magnitude of associations between internalized stigma and intrinsic motivation and internalized stigma and amotivation among the first episode and prolonged samples. Next, we conducted stepwise regressions to examine whether internalized stigma was associated with intrinsic motivation above and beyond associations with amotivation in each sample. Results: In the early phase sample, the association between internalized stigma was greater with intrinsic motivation (r=-0.48, p=.00) compared to amotivation (r=0.27, p=0.10). Associations with internalized stigma in the prolonged sample were also greater with intrinsic motivation (r=-0.30, p=0.02) versus amotivation (r=0.19, p=0.12). The magnitude of the associations between internalized stigma and intrinsic motivation (z=1.03, p=0.15) and between internalized stigma and amotivation (z=0.41, p = 0.34) did not significantly differ when comparing phase of illness. Regression analyses indicated that, controlling for amotivation,
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Background: Motivation deficits predict decreased functioning in schizophrenia. Recent work suggests deficits reflect challenges in separate domains: intrinsic motivation (one's internal drive to engage in a behavior out of enjoyment or interest) and amotivation (one's broader decrease in motivated behavior linked to avolition and anhedonia). Internalized stigma is another determinant of functioning for people with schizophrenia that may impact motivation. However, little is known about these relationships, including which aspects of motivation it may impact nor when these links emerge. Identifying the link between these constructs may help to identify whether internalized stigma may be a novel treatment target to facilitate improvements in motivation. Methods: Forty adults with early phase schizophrenia and 66 adults with prolonged schizophrenia completed measures of internalized stigma, intrinsic motivation, and amotivation. Pearson's correlations were examined followed by Fischer's r-to-z transformations to compare differences in the magnitude of associations between internalized stigma and intrinsic motivation and internalized stigma and amotivation among the first episode and prolonged samples. Next, we conducted stepwise regressions to examine whether internalized stigma was associated with intrinsic motivation above and beyond associations with amotivation in each sample. Results: In the early phase sample, the association between internalized stigma was greater with intrinsic motivation (r=-0.48, p=.00) compared to amotivation (r=0.27, p=0.10). Associations with internalized stigma in the prolonged sample were also greater with intrinsic motivation (r=-0.30, p=0.02) versus amotivation (r=0.19, p=0.12) . The magnitude of the associations between internalized stigma and intrinsic motivation (z=1.03, p=0.15) and between internalized stigma and amotivation (z=0.41, p = 0.34) did not significantly differ when comparing phase of illness. Regression analyses indicated that, controlling for amotivation, internalized stigma predicted intrinsic motivation in both the prolonged sample (R2=0.09, F(1,64) =6.18, p=0.02) and the early phase schizophrenia sample (R2=0.23, F(1,37)=10.98, p=.00). Discussion: Results suggest internalized stigma has a stronger relationship with intrinsic motivation separate from, and above and beyond, its association with amotivation. Findings support models of intrinsic and amotivation being distinct domains. Links between internalized stigma and motivation appear to emerge and persist from the early stages of schizophrenia, suggesting that targeting stigma in early intervention services may help to improve intrinsic motivation in people with schizophrenia. Methods: 26 individuals with schizophrenia and 26 matched controls took part in the study. We evaluated communicative pragmatic-ability using the lingusitic and extralinguistic scales of the Assement Battery for Communication (ABaCo). We assessed EF -working memory, inhibition and cognitive flexibility-, ToM and background cognitive functions -general intelligence, selective attention and speed processing -using a battery of standardized neuropsychological tests. Results: To investigate the presence of significant differences in communicative-pragmatic performance between patients and controls, we performed a 2x3 ANOVA with participant (individuals with schizophrenia, healthy control) as between-subjects factor, and the type of pragmatic phenomena (sincere, deceitful and ironic) as within-subjects factor. For each of the ABaCo subscales, we found a main effect of participant (.0001 < p. < .001), showing that experimental group performed significantly worse than control group. We also found a linear trend in pragmatic performance (.0001 < p. < .008), that revealed a linear decrease in scores depending on the pragmatic phenomenon investigated: sincere communicative acts were the easiest to understand, followed by deceit and irony. To evaluate the role of cognitive and ToM tasks on pragmatic performance in patients, we performed a regression analysis. We included relevant predictors in the model, i.e. cognitive background factors, EF and ToM. We found that the only significant predictor was ToM, that contributed to increase the quote of explained variance in the comprehension and production of linguistic sincere communicative acts (p = .005) and linguistic deceit (p. = .009). Discussion: Results showed that individuals with schizophrenia performed poorly in the comprehension and production of different kinds of pragmatic phenomena, i.e. sincere, deceitful and ironic communicative acts. This result confirms that communicative-pragmatic impairment is a core deficit in schizophrenia. In addition, we found an association between ToM and comprehension and production of sincere and deceitful communicative acts, while no association between irony and ToM was found. et al, 2016) . NAVIGATE included tailored medication, individual resiliency training, family education, and supported education and employment. Family burden has been identified as a key factor in FEP, with high levels of distress often found in relatives. Here, we look at the presence and predictors of family burden in relatives in the RAISE-ETP sample over the two years of study participation. Methods: A total of 404 individuals between ages 15 and 40 were enrolled. DSM-IV diagnoses of non-affective psychosis were included. All participants had experienced only one episode of psychosis, had been prescribed less than 6 months of lifetime psychotic medication, spoke English, and provided informed consent. Participants were offered a minimum of two years of CSC or customary care. At baseline, participants provided demographic and clinical history information; they were administered the Heinrichs-Carpenter Quality of Life Scale (QOL) and the Positive and Negative Symptom Scale (PANSS) regularly throughout the study. Each participant was asked to nominate a family member for administration of the Burden Assessment Scale (BAS) throughout the study. The BAS yields a total score, as well as subscales assessing disrupted activities, personal distress, guilt, time perspective, and worry. Results: Fifty-seven percent of the participants nominated a relative who was assessed with the BAS. Interestingly, the only statistically significant independent predictors of baseline family burden were relatives' reports of their loved ones' dependence and lack of help with chores; no consumer demographic, PANSS, or QOL variables were identified. BAS total scores improved significantly in both conditions, but significantly more in NAVIGATE. Consumer report of better family relationship quality on the QOL was associated with significantly less family burden on the BAS over time, but neither PANSS positive, negative or symptom total, total QOL, nor participation in specific CSC psychosocial components mediated the observed BAS total burden reductions. With regard to the BAS burden components, there was a main effect of improvement over time on family disrupted activities, guilt, time perspective, and worry, with disrupted activities, personal distress, and guilt all evidencing a time by group interaction favoring greater reductions in NAVIGATE. Discussion: As anticipated, family burden is widely evidenced in the relatives of US FEP consumers who are new to treatment. This burden does not appear to reflect unique consumer characteristics. There appears to be a reduction in family burden during the loved one's FEP treatment, with that reduction enhanced when the consumer is participating in a more intensive CSC program. Interestingly, while many potential intervening variables were tested as mediators of the CSC impact on family burden, none were identified. 
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Background: Schizophrenia is increasing recognized to be associated with symptoms of depression. As many as 40% of people with schizophrenia (SCZ) have a fully syndromal major depressive episode at some time in their lives and the mean severity of depression in unselected samples is often in the mildly to moderately depressed range (mean BDI score of 11-16). While patients who report no depression have been found to report very low levels of subjective distress, a comprehensive study of the subjective quality of life correlates of depression in schizophrenia has not been performed. Further, given the impact of depression on interpersonal functioning, an assessment of the relationships between depression and social cognition is warranted. Methods: Two samples of patients with SCZ (n's= 179 and 218) were compared to samples of HC (n's= 104 and 154) and were examined with selfreported measures of depression (Beck Depression Inventory-II; BDI), social cognition, and everyday functioning and performed a total of 14 different social cognition performance-based tests. Some of these tests measured attribution bias (AIHQ), while others measured interpersonal sensitivity (PADS, PID5) while others were performance based tests of emotion recognition and perception as well as social inference and theory of mind. Participants were also examined for their speed of completion of the tasks and their confidence in their accuracy. Patients were also clinically rated with the PANSS. Results: In both samples, SCZ patients were more depressed than HC (15,15, vs. 6 and 6) . In both samples of SCZ, BDI scores were correlated with clinical ratings of depression (PANSS item 6: r's=.60 and .61. Performance on tests of emotion recognition and perception, social inference, and theory of mind were not correlated with BDI in either sample. In both samples, higher BDI were correlated with self-reports of more impaired everyday functioning, lower subjective impressions of social cognitive competence, and greater feelings of interpersonal sensitivity, combined with the impression that others were mistreating them. Depression in HC, but not patients, was associated with lower confidence while performing social cognitive tests and depression in SCZ, but not HC, was associated with slower performance on these same tests. Discussion: Depressed mood impacts self assessment of abilities and global world views in very similar ways in HC and people with SCZ. These impressions are not due to objective impairments in performance that are associated with depression. In contrast, objective performance on social cognitive tests, like previous studies of the relationship of neurocognition and functional and depression, shows remarkably little overlap with subjective depression. Although the similarity of the relationships between depression, interpersonal sensitivity, and subjective quality of life are similar in HC and SCZ, the more severe depression on the part of the SCZ populations suggests that this is an area of considerable importance for clinical intervention with either pharmacological or psychotherapeutic interventions.
